{
  "top_biomarkers": {
    "methylation_11": 0.03925495912007772,
    "methylation_6": 0.0365749730911419,
    "mutation_1": 0.035918892770630824,
    "methylation_18": 0.034514699331035646,
    "methylation_10": 0.03293923276188466,
    "methylation_7": 0.032792891641088735,
    "methylation_17": 0.032621140477689506,
    "methylation_12": 0.032363527710231474,
    "methylation_5": 0.03233724973341945,
    "methylation_4": 0.03166865622043958,
    "methylation_15": 0.029078419150973103,
    "methylation_1": 0.027292600188624797,
    "methylation_16": 0.026229649888468525,
    "methylation_0": 0.025448816879509967,
    "methylation_9": 0.025088516194978854,
    "methylation_13": 0.024257170463385602,
    "mutation_2": 0.024069223286465873,
    "mutation_0": 0.02350398750848086,
    "methylation_3": 0.02322185100159087,
    "methylation_14": 0.02292694621244267
  },
  "biomarker_categories": {
    "methylation": [
      "methylation_11",
      "methylation_6",
      "methylation_18",
      "methylation_10",
      "methylation_7",
      "methylation_17",
      "methylation_12",
      "methylation_5",
      "methylation_4",
      "methylation_15",
      "methylation_1",
      "methylation_16",
      "methylation_0",
      "methylation_9",
      "methylation_13",
      "methylation_3",
      "methylation_14"
    ],
    "mutation": [
      "mutation_1",
      "mutation_2",
      "mutation_0"
    ],
    "cn_alteration": [],
    "fragmentomics": [],
    "clinical": [],
    "icgc_argo": []
  },
  "biological_implications": {
    "methylation": {
      "description": "DNA methylation patterns in cancer",
      "clinical_relevance": "Epigenetic modifications that could indicate cancer progression",
      "therapeutic_potential": "Targets for epigenetic therapy drugs"
    },
    "mutation": {
      "description": "Somatic mutations in cancer cells",
      "clinical_relevance": "Diagnostic and prognostic markers",
      "therapeutic_potential": "Targetable mutations for precision medicine"
    }
  }
}